Health Canada sticks with Evusheld despite U.S. FDA dropping the COVID drug
While Health Canada says it is "aware" of the U.S. decision to withdraw the emergency use of Evusheld, a drug by AstraZeneca used to help prevent COVID-19 infection--- the agency is maintaining its approval, citing the differences in variant circulation between Canada and the U.S.
The U.S. Food and Drug Administration (FDA) announced on Jan. 26 that its emergency use authorization of the drug was pulled due to its inefficacy in treating “certain” COVID-19 variants.
The FDA stated in a release on its website that as the XBB.1.5. variant, nicknamed “Kraken”, is making up the majority of cases in the country, the use of Evusheld is “not expected to provide protection” and therefore not worth exposing the public to possible side effects of the drug, like allergic reactions.
In an email to CTVNews.ca, Health Canada said the U.S. Food and Drug Administration pulled the drug as the main variant of concern in the U.S. is XBB.1.5.
"Dominant variants in the [U.S.] may be different from those circulating in Canada," the federal agency said in an email. "The most recent epidemiological data in Canada (as of January 1, 2023) indicate that BA.5 (Omicron) subvariants continue to account for more than 89 per cent of reported cases."
On Jan. 6 the FDA said in press release that certain variants are not neutralized by Evusheld and cautioned people who are exposed to XBB.1.5. On Jan. 26, the FDA then updated its website by saying it would be limiting the use of Evusheld.
"Evusheld is not currently authorized for use in the U.S. until further notice by the Agency," the FDA website states.
On Jan. 17, Health Canada issued a "risk communication" on Evusheld, explaining how it may not be effective against certain Omicron subvariants when used as a preventative measure or treatment for COVID-19.
"Decisions regarding the use of EVUSHELD should take into consideration what is known about the characteristics of the circulating COVID-19 variants, including geographical prevalence and individual exposure," Health Canada said in an email.
Health Canada says Evusheld does neutralize against Omicron subvariant BA.2, which according to the agency, is the dominant variant in many communities in Canada.
The drug was introduced for prevention measures specifically for people who have weaker immune systems and are unlikely to be protected by a COVID-19 vaccine. It can only be given to people 12 years and older.
"EVUSHELD is not a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended," the agency's website reads.
Health Canada says no drug, including Evusheld, is a substitute for vaccination.
COVID-19 COVERAGE
CTVNews.ca Top Stories
TREND LINE | Poilievre surpasses Trudeau when it comes to preferred prime minister: Nanos
The federal Liberals are trending downward on three key measures while Conservative Leader Pierre Poilievre has surpassed Prime Minister Justin Trudeau when it comes to the question of who Canadians would prefer now as their prime minister, according to Nanos Research.

BREAKING | Responding to Indigenous, Vatican rejects Discovery Doctrine
The Vatican on Thursday responded to Indigenous demands and formally repudiated the 'Doctrine of Discovery,' the theories backed by 15th-century 'papal bulls' that legitimized the colonial-era seizure of Native lands and form the basis of some property law today.
opinion | This is how much debt is normal for your age
Have you ever stopped to wonder how much debt is typical for your age?
'Leave this with me': Alberta premier heard on call with COVID-19 protester
Alberta Premier Danielle Smith, in a leaked cellphone call, commiserated with a COVID-19 protester about his trial while divulging to him there was an internal dispute over how Crown prosecutors were handling COVID-19 cases.
As Canadians miss out on benefits, Ottawa promises automatic tax filing is on the way
The Canada Revenue Agency will pilot a new automatic system next year to help vulnerable Canadians who don't file their taxes get their benefits. This week's federal budget says the Canada Revenue Agency will also present a plan in 2024 to expand the service, following consultations with stakeholders and community organizations.
Canada makes amendments to foreign homebuyers ban – here's what they look like
Months after Canada's ban on foreign homebuyers took effect on Jan. 1, the Canada Mortgage and Housing Corporation has made several amendments to the legislation allowing non-Canadians to purchase residential properties in certain circumstances.
'It's going to take the community': Yukon faces Canada's worst toxic drug death rate
When the doors close at night at the administration office at Yukon's Carcross Tagish First Nation, a van hits the road and drives through the communities to offer naloxone to reverse overdoses, drug testing kits, food and even a friendly face to help those struggling because of the opioid crisis.
What is the grocery rebate in federal budget 2023? Key questions, answered
To help offset rising living expenses, the Government of Canada has introduced a one-time grocery rebate for low- and modest-income Canadians. Here is what we know about the rebate.
'A freeze response of shock': Expert weighs in on bystanders not stepping in during fatal Vancouver stabbing
After a man was fatally stabbed outside of a Vancouver Starbucks in front of dozens of witnesses, video of the attack is circulating on social media, raising questions about why nobody stepped in to help.